Orna Mor

5.4k total citations
103 papers, 2.3k citations indexed

About

Orna Mor is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Orna Mor has authored 103 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Infectious Diseases, 26 papers in Epidemiology and 20 papers in Molecular Biology. Recurrent topics in Orna Mor's work include SARS-CoV-2 and COVID-19 Research (28 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (18 papers). Orna Mor is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (28 papers), HIV Research and Treatment (18 papers) and HIV/AIDS Research and Interventions (18 papers). Orna Mor collaborates with scholars based in Israel, United States and Italy. Orna Mor's co-authors include Ella Mendelson, Elena Feinstein, Neta S. Zuckerman, Itzchak Levy, Yaniv Lustig, Rami Skaliter, Ada Rozen, Dena Leshkowitz, Elena Zelin and Ayelet Chajut and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and PLoS ONE.

In The Last Decade

Orna Mor

97 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Orna Mor 1.1k 760 328 252 214 103 2.3k
Laurens Liesenborghs 410 0.4× 784 1.0× 370 1.1× 112 0.4× 209 1.0× 40 1.5k
Simone Kashima 534 0.5× 596 0.8× 245 0.7× 144 0.6× 133 0.6× 179 2.3k
Qibin Leng 534 0.5× 766 1.0× 388 1.2× 233 0.9× 127 0.6× 64 2.3k
Rajesh Kannangai 534 0.5× 929 1.2× 956 2.9× 444 1.8× 257 1.2× 134 2.5k
Zhisheng Her 1.1k 1.0× 259 0.3× 232 0.7× 151 0.6× 84 0.4× 31 2.1k
Joost Louwagie 1.3k 1.2× 531 0.7× 339 1.0× 1.5k 6.0× 131 0.6× 27 2.4k
A. Benedetto 509 0.5× 630 0.8× 721 2.2× 524 2.1× 242 1.1× 94 2.1k
Min Wu 825 0.8× 859 1.1× 1.2k 3.5× 112 0.4× 268 1.3× 63 2.5k
T Izumi 530 0.5× 480 0.6× 415 1.3× 840 3.3× 48 0.2× 86 1.8k
Jun Komano 618 0.6× 816 1.1× 428 1.3× 441 1.8× 73 0.3× 83 2.5k

Countries citing papers authored by Orna Mor

Since Specialization
Citations

This map shows the geographic impact of Orna Mor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orna Mor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orna Mor more than expected).

Fields of papers citing papers by Orna Mor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Orna Mor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orna Mor. The network helps show where Orna Mor may publish in the future.

Co-authorship network of co-authors of Orna Mor

This figure shows the co-authorship network connecting the top 25 collaborators of Orna Mor. A scholar is included among the top collaborators of Orna Mor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orna Mor. Orna Mor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mor, Orna, et al.. (2024). Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023. Viruses. 16(3). 480–480. 16 indexed citations
3.
Davidov, Yana, Victoria Indenbaum, Michal Mandelboim, et al.. (2023). Reduced Neutralization Efficacy against Omicron Variant after Third Boost of BNT162b2 Vaccine among Liver Transplant Recipients. Viruses. 15(1). 253–253. 1 indexed citations
4.
Levy, Itzchak, Daniel Elbirt, Eduardo Shahar, et al.. (2023). Factors Associated with Virological Failure in First-Line Antiretroviral Therapy in Patients Diagnosed with HIV-1 between 2010 and 2018 in Israel. Viruses. 15(12). 2439–2439. 4 indexed citations
5.
Mbuagbaw, Lawrence, Bluma Brenner, Diego Cecchini, et al.. (2023). Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended use. The Lancet HIV. 10(10). e684–e689. 5 indexed citations
6.
Popping, Stephanie, Valeria Cento, Carole Seguin‐Devaux, et al.. (2021). The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures. Viruses. 14(1). 16–16. 4 indexed citations
7.
Shitrit, Pnina, et al.. (2021). Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021. Eurosurveillance. 26(39). 42 indexed citations
8.
Zuckerman, Neta S., Neta S. Zuckerman, Efrat Bucris, et al.. (2021). A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel. Vaccines. 9(6). 616–616. 22 indexed citations
9.
Levy, Itzchak, Anat Wieder-Finesod, Asaf Biber, et al.. (2021). Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1. Clinical Microbiology and Infection. 27(12). 1851–1855. 112 indexed citations
10.
Chowers, Michal, Daniel Chemtob, Orna Mor, et al.. (2020). Continuum of HIV care of newly diagnosed individuals in Israel, 2011–2015: a population-based cohort study. International Journal of STD & AIDS. 31(4). 326–334. 1 indexed citations
11.
Houri, Inbal, Ziv Ben‐Ari, Amir Shlomai, et al.. (2020). Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trial. BMC Infectious Diseases. 20(1). 264–264. 5 indexed citations
12.
Harari, Sheri, Talia Kustin, Dana G. Wolf, et al.. (2020). Drivers of within-host genetic diversity in acute infections of viruses. PLoS Pathogens. 16(11). e1009029–e1009029. 19 indexed citations
13.
Levy, Itzchak, ‪Yasmin Maor‬‏, Naim Mahroum, et al.. (2016). Missed opportunities for earlier diagnosis of HIV in patients who presented with advanced HIV disease: a retrospective cohort study. BMJ Open. 6(11). e012721–e012721. 41 indexed citations
14.
Manor, Yosef, Daniela Ram, Nili Daudi, et al.. (2016). Evidence for Hepatitis A virus endemic circulation in Israel despite universal toddlers' vaccination since 1999 and low clinical incidence in all age groups. The Journal of Infectious Diseases. 215(4). jiw611–jiw611. 11 indexed citations
15.
Ram, Daniela, Dena Leshkowitz, Dimitri Gonzalez, et al.. (2014). Evaluation of GS Junior and MiSeq next-generation sequencing technologies as an alternative to Trugene population sequencing in the clinical HIV laboratory. Journal of Virological Methods. 212. 12–16. 17 indexed citations
16.
Timothy, Nigel H., Allen C. Clermont, Susan L. Rook, et al.. (2005). Diabetes–Induced Abnormalities in Retinal Vascular Permeability (RVP) & Electroretinogram (ERG) Are Normalized in RTP801/REDD1 Knockout (KO) Mice. Investigative Ophthalmology & Visual Science. 46(13). 427–427. 1 indexed citations
17.
Pinthus, Jehonathan H., Eddie Fridman, Benjamin Dekel, et al.. (2004). ErbB2 IS A TUMOR ASSOCIATED ANTIGEN AND A SUITABLE THERAPEUTIC TARGET IN WILMS TUMOR. The Journal of Urology. 172(4 Part 2). 1644–1648. 16 indexed citations
18.
Shoshani, Tzipora, Alexander Faerman, Igor Mett, et al.. (2002). Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, RTP801 , Involved in Apoptosis. Molecular and Cellular Biology. 22(7). 2283–2293. 479 indexed citations
19.
Duhig, Trevor, Christiana Ruhrberg, Orna Mor, & Mike Fried. (1998). The Human Surfeit Locus. Genomics. 52(1). 72–78. 29 indexed citations
20.
Mor, Orna, Pnina Yaron, Monika Huszar, et al.. (1997). Absence of p53 Mutations in Malignant Mesotheliomas. American Journal of Respiratory Cell and Molecular Biology. 16(1). 9–13. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laurens Liesenborghs Breakdown of academic impact, for papers by Simone Kashima Breakdown of academic impact, for papers by Qibin Leng Breakdown of academic impact, for papers by Rajesh Kannangai Breakdown of academic impact, for papers by Zhisheng Her Breakdown of academic impact, for papers by Joost Louwagie Breakdown of academic impact, for papers by A. Benedetto Breakdown of academic impact, for papers by Min Wu Breakdown of academic impact, for papers by T Izumi Breakdown of academic impact, for papers by Jun Komano
Rankless by CCL
2026